Waiting
Login processing...

Trial ends in Request Full Access Tell Your Colleague About Jove

Validation of FAM83A as a Target Gene in Cervical Cancer

February 9th, 2024
*1, *2, 1, 3
1Department of Obstetrics and Gynecology, Jingzhou Hospital, Yangtze University, 2Department of Obstetrics and Gynaecology, Gong An County People's Hospital, 3Department of Ultrasound, Zhijiang People's Hospital
* These authors contributed equally

Summary
Automatic Translation

Here, we show the procedures for FAM83A knockdown; the assays to detect its effects on proliferation, migration, and invasion of cervical cancer cells; and the sensitization of these cells to cisplatin. This study provides a promising target gene for cervical cancer and a reference for further drug research.

Article

Get cutting-edge science videos from JoVE sent straight to your inbox every month.

Waiting X
Simple Hit Counter